3beta-hydroxyandrost-5-en-17-oneFinding
3beta-hydroxyandrost‑5-en‑17-one has no detected effect on Beck Depression Inventory (BDI) total score
no difference foundLimited evidenceFindingreplicated ×1
01 · The sentence it was drawn from
“A paired samples t test revealed that the Beck Depression Inventory (BDI) scores were not significantly different (p >.5) between the DHEA condition (M= 2.08, SD = 2.04) and the placebo condition (M = 2.63, SD = 2.93).”
3beta-hydroxyandrost-5-en-17-one
Beck Depression Inventory (BDI) total score
no difference found
- Who
- postmenopausal women aged 55-80 not using hormone replacement therapy, DHEA versus lactose placebo crossover with a 1-week washout
- Dose studied
- 50 mg oral DHEA daily (capsules compounded by Belmar Pharmaceutical) for one 4-week period
Limited evidencePMID 21942436 · 2011
02 · The study
- Study
- crossover
- Duration
- 4 weeks
Evidence, by strength
- strong
- moderate
- limitedthis finding
- very limited
- insufficient
03 · The paper
Behavioral neuroscience04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7GY9V9E487G28E4503SRJ88